Declining China Dat...
Health Care: Health Services
Ironwood Pharmaceuticals Inc. (IRWD: NASDAQ)
$12.52 -0.39 | -3.02%
05/23/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 136.70M | 87.28M | 44.32M | 123.14M |
| Receivables | 1.49M | 652.00K | 2.90M | 5.23M |
| Inventories | 6.70M | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 184.44M | 167.57M | 259.08M | 131.45M |
| Property, Plant & Equipment, Gross | 74.52M | 59.38M | 51.30M | 36.54M |
| Accumulated Depreciation & Depletion | 36.98M | 25.76M | 16.93M | 13.98M |
| Property, Plant & Equipment, Net | 37.54M | 33.62M | 34.37M | 22.55M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 7.93M | 7.78M | 7.92M | 8.45M |
| Total Non-Current Assets | 45.47M | 41.41M | 42.29M | 31.00M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 229.91M | 208.98M | 301.36M | 162.45M |
| Accounts Payable | 21.73M | 6.44M | 4.30M | 4.94M |
| Short Term Debt | 261.00K | 233.00K | 197.00K | 1.45M |
| Other Current Liabilities | 0.00 | 4.04M | 2.80M | 0.00 |
| Total Current Liabilities | 54.94M | 65.13M | 64.43M | 56.44M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 1.76M |
| Deferred Income Taxes | 11.59M | 12.44M | 14.61M | 0.00 |
| Other Non-Current Liabilities | 19.02M | 21.13M | 62.38M | 104.13M |
| Minority Interest | 0.00 | 0.00 | 1.12M | -2.13M |
| Total Non-Current Liabilities | 30.92M | 33.99M | 77.39M | 407.57M |
| Total Liabilities | 85.86M | 99.12M | 141.81M | 464.00M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 144.05M | 109.86M | 159.55M | -301.55M |
| Common Par | 108.00K | 101.00K | 99.00K | 8.00K |
| Additional Paid In Capital | 648.96M | 542.14M | 526.99M | 13.00M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -505.02M | -432.39M | -367.54M | -314.56M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 5.00K | 6.00K | 1.00K | 0.00 |
| Total Capitalization | 144.05M | 109.86M | 159.55M | -299.79M |
| Total Equity | 144.05M | 109.86M | 159.55M | -301.55M |
| Total Liabilities & Stock Equity | 229.91M | 208.98M | 301.36M | 162.45M |
| Total Common Shares Outstanding | 107.77M | 100.72M | 99.17M | 94.91M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 106.40M | 99.87M | 89.65M | 7.12M |
| Diluted Weighted Shares Outstanding | 106.40M | 99.87M | 89.65M | 7.12M |
| Number of Employees | 530 | 276 | 217 | 165 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with IRWD
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Pharma Stocks With Upside
- ProBridger Management
- ContributorRocket Stocks for the Week ...
- ContributorBarron's Insider Purchases ...
Latest IRWD Headlines from TheStreet
- Ironwood Pharmaceuticals Is Now Oversold (IRWD) 05.22.13 | 04:05 pm
- Ironwood Pharmaceuticals Enters Oversold Territory (IRWD) 05.01.13 | 12:05 pm
- 3 Stocks Underperforming Today In The Health Services Industry 04.25.13 | 01:04 pm
- Ironwood's Constipation Drug Sales Disappoint 04.23.13 | 08:04 am
- Top Insider Trades: ATVI, SCS, KSS, IRWD 04.03.13 | 07:04 am
- Analysts' Actions: FCX IRWD RIG SCHW ULTA 03.15.13 | 08:03 am
- Cramer's 'Mad Money' Recap: The Bullish Facts 01.17.13 | 08:01 pm
- Ironwood Pharmaceuticals Inc. Stock Downgraded (IRWD) 01.17.13 | 04:01 am
- Analysts' Actions: AAPL DELL IRWD K SEE FB 01.16.13 | 08:01 am
- 5 Stocks Set to Soar on Bullish Earnings 01.14.13 | 12:01 pm
Press Releases for IRWD
- Edward Owens, Ironwood Board Of Directors (Photo: Business Wire) - Business Wire 03.04.13 | 08:03 am
- Ironwood Pharmaceuticals To Present At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 04:02 pm
- Mark Currie, Ph.D., Senior Vice President, CSO, And President Of R&D Of Ironwood Pharmaceuticals, Inc. (Photo: Business Wire) - Business Wire 02.11.13 | 09:02 am
- Ironwood Pharmaceuticals Provides Fourth Quarter 2012 Investor Update - Business Wire 01.15.13 | 07:01 am
- Ironwood Pharmaceuticals To Host Fourth Quarter 2012 Investor Update Call - Business Wire 01.10.13 | 04:01 pm
- Ironwood Completes $175 Million Debt Offering - Business Wire 01.04.13 | 10:01 am
- Ironwood Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 04:01 pm
- FACT SHEET -- Chronic Idiopathic Constipation - Business Wire 12.17.12 | 08:12 am
- Protagonist And Ironwood Expand Peptide Drug Discovery Collaboration - Business Wire 12.06.12 | 08:12 am
- Constella® (linaclotide) Approved In Europe For The Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C)in Adults - PR Newswire 11.28.12 | 10:11 am
Partner Headlines for IRWD
- Pre-Market Most Active for May 22, 2013 : NTAP, PFE, NMR, RDS/A, RDS/B, NOK, SNE, PGTI, IRWD, GILD, VOD, ZNGA - NASDAQ 05.22.13 | 12:05 pm
- EU Approval for Ironwood's Constella - Analyst Blog - Zacks 11.30.12 | 02:11 pm
- Earnings Scorecard: Forest Labs - Analyst Blog - Zacks 10.26.12 | 06:10 pm
- Ironwood and AstraZeneca Announce Linaclotide Collaboration for China - Benzinga 10.23.12 | 09:10 am
- FDA OK's Forest-Ironwood's Linzess - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
- FDA OK's Forest-Ironwood's Linzess - Analyst Blog - Zacks 08.31.12 | 05:08 pm
- Hedging Ironwood before ruling - NASDAQ 08.28.12 | 09:08 am
- Ironwood Pharmaceuticals, Earnings Call INSIGHTS: Huge Opportunity in CC, Feeling Good About Commercial Readiness - Wall St. Cheat Sheet 07.18.12 | 11:07 am
- Delay in Forest Drug FDA Action Date - Analyst Blog - Zacks 03.30.12 | 05:03 pm
- Forest-Janssen Sue Generic Players - Analyst Blog - Zacks 03.16.12 | 07:03 pm
